New York
New York
212-643-8811 ext. 327 121 West 36th Street #201 New York, NY 10018

Category

Notes & Papers
It has now been two years since new final regulations from SAMHSA and the DEA regarding buprenorphine and methadone provided greater flexibilities for the treatment of Opioid Use Disorder (OUD). The Coalition of Medication-Assisted Treatment Providers and Advocates (COMPA) is hosting a full-day symposium to examine the impact of those changes, the first set of...
Continue Reading
It has now been two years since new final, regulations from SAMHSA and the DEA regarding buprenorphine and methadone provided greater flexibilities for the treatment of Opioid Use Disorder (OUD). The Coalition of Medication-Assisted Treatment Providers and Advocates (COMPA) is hosting a full-day symposium to examine the impact of those changes—the first set of comprehensive...
Continue Reading
When Shatterproof launched its new ATLAS (Addiction Treatment Locator, Assessment, and Standards Platform) project, funded largely by insurance companies, as a pilot in six states, opioid treatment programs (OTPs) of New York State said yes, they want to participate. The reason is not because OTPs are interested in having disgruntled patients post complaints in a...
Continue Reading
When Shatterproof launched its new ATLAS (Addiction Treatment Locator, Assessment, and Standards Platform) project, funded largely by insurance companies, as a pilot in six states, opioid treatment programs (OTPs) of New York State said yes, they want to participate. The reason is not because OTPs are interested in having disgruntled patients post complaints in a...
Continue Reading
When Shatterproof launched its new ATLAS (Addiction Treatment Locator, Assessment, and Standards Platform) project, funded largely by insurance companies, as a pilot in six states, opioid treatment programs (OTPs) of New York State said yes, they want to participate. The reason is not because OTPs are interested in having disgruntled patients post complaints in a...
Continue Reading
When Shatterproof launched its new ATLAS (Addiction Treatment Locator, Assessment, and Standards Platform) project, funded largely by insurance companies, as a pilot in six states, opioid treatment programs (OTPs) of New York State said yes, they want to participate. The reason is not because OTPs are interested in having disgruntled patients post complaints in a...
Continue Reading
When Shatterproof launched its new ATLAS (Addiction Treatment Locator, Assessment, and Standards Platform) project, funded largely by insurance companies, as a pilot in six states, opioid treatment programs (OTPs) of New York State said yes, they want to participate. The reason is not because OTPs are interested in having disgruntled patients post complaints in a...
Continue Reading
When Shatterproof launched its new ATLAS (Addiction Treatment Locator, Assessment, and Standards Platform) project, funded largely by insurance companies, as a pilot in six states, opioid treatment programs (OTPs) of New York State said yes, they want to participate. The reason is not because OTPs are interested in having disgruntled patients post complaints in a...
Continue Reading
When Shatterproof launched its new ATLAS (Addiction Treatment Locator, Assessment, and Standards Platform) project, funded largely by insurance companies, as a pilot in six states, opioid treatment programs (OTPs) of New York State said yes, they want to participate. The reason is not because OTPs are interested in having disgruntled patients post complaints in a...
Continue Reading
1 2 3 … 5